Abstract: A system, method, and apparatus for treating a medical condition by applying transcutaneous electrical stimulation to a target peripheral nerve of a subject. Electrical stimulation is applied to the peripheral nerve via a stimulation electrode pattern under closed-loop control in which EMG responses are monitored and used to adjust stimulation parameters. In response to detecting an unacceptable recording, electrical stimulation is applied to the peripheral nerve under open-loop control.

Abstract: An azaaryl derivative with the structure of formula (I), a preparation method therefor and a pharmaceutical use thereof are disclosed in this application. The series of compounds of the this application can be widely applied in the preparation of drugs for treating cancer, tumor, autoimmune disease, metabolic disease or metastatic disease, particularly for treating ovarian cancer, pancreatic cancer, prostate cancer, breast cancer, cervical cancer, glioblastoma, multiple myeloma, metabolic disease, neurodegenerative disease, primary site tumor metastasis or osseous metastasis cancer, and are expected to be developed into a new generation of CSF-1R inhibitor drugs.

Abstract: An in-vehicle gateway communication method includes receiving a first message from a first in-vehicle device. An in-vehicle gateway identifies identification information in the first message, and matches the identification information with preset identification information stored in the in-vehicle gateway, and only when the matching succeeds, the in-vehicle gateway sends a second message, to indicate, using the second message, a second in-vehicle device to perform a target operation. When the identification information in the first message does not match the preset identification information stored in the gateway, the in-vehicle gateway does not send the second information to control the second in-vehicle device to perform the target operation. Therefore, identification information of a first message is set in an in-vehicle gateway of a vehicle.

Abstract: A network architecture for updating control units in a remote network such as in a vehicle comprises an administration module, a verification module and an agent module. The administration module formulates a policy for governing the update of control units based on context information about the control units provided to the administration module. In formulating the policy, the administration unit takes account of compatibility between the control units with regard to versions of the update so that the update can succeed. Or, if the update fails in whole or part, a stable state of the remote network can nevertheless still be obtained, since the administration module may provide error handling procedures for the agent module when errors are encountered during update.

Abstract: An integrated structure for exporting battery power (100), a battery pack (200), and a vehicle (300) are disclosed herein. The integrated structure for exporting battery power (100) includes an end plate (21) as a part of a battery pack housing and a copper bar for leading out two electrodes of a battery (10) to outside of the battery pack housing, where the end plate (21) is made of an insulating material, and the copper bar is encapsulated in the end plate (21) by injection molding, electrical connection portions of the copper bar being exposed.

Abstract: An information storage system and apparatus relate to the field of automatic control technologies in order to resolve a problem that there is little information for diagnosing a fault that is stored using a freeze frame. The system includes at least one subcontroller configured to obtain a parameter value corresponding to a parameter, and send the parameter and the parameter value corresponding to the parameter to a management controller, the management controller configured to send the received parameter and the received parameter value corresponding to the parameter to a vehicle-intelligent device, and the vehicle-intelligent device is configured to receive and store the parameter and the parameter value corresponding to the parameter, where each subcontroller is coupled to at least one executor, and the management controller is coupled to each subcontroller of the at least one subcontroller.

Abstract: An azaaryl derivative with the structure of formula (I), a preparation method therefor and a pharmaceutical use thereof are disclosed in this application. The series of compounds of the this application can be widely applied in the preparation of drugs for treating cancer, tumor, autoimmune disease, metabolic disease or metastatic disease, particularly for treating ovarian cancer, pancreatic cancer, prostate cancer, breast cancer, cervical cancer, glioblastoma, multiple myeloma, metabolic disease, neurodegenerative disease, primary site tumor metastasis or osseous metastasis cancer, and are expected to be developed into a new generation of CSF-1R inhibitor drugs.

Abstract: This application describes a nitrogen heteroaryl derivative having CSF1R inhibitory activity, and a preparation method therefor and an application thereof. Compounds in the present invention has a structure represented by formula (I) as below, and the definition on substituents is as stated in the description and the claims. The compounds in the this application can be widely applied to preparation of drugs for treating cancer, tumor, autoimmune disease, metabolic disease, or metastatic disease, in particular ovarian cancer, pancreatic cancer, prostate cancer, breast cancer, cervical cancer, glioblastoma, multiple myeloma, metabolic disease, neurodegenerative disease, metastasis of primary tumor sites, or osseous metastatic cancer, and a new generation of CSF1R inhibitor drugs is expected to be developed.

Abstract: A system, method, and apparatus for treating a medical condition by applying transcutaneous electrical stimulation to a target peripheral nerve of a subject. Electrical stimulation is applied to the peripheral nerve via a stimulation electrode pattern under closed-loop control in which EMG responses are monitored and used to adjust stimulation parameters. In response to detecting an unacceptable recording, electrical stimulation is applied to the peripheral nerve under open-loop control.

Abstract: A system, method, and apparatus for treating a medical condition by applying transcutaneous electrical stimulation to a target peripheral nerve of a subject. Electrical stimulation is applied to the peripheral nerve via a stimulation electrode pattern under closed-loop control in which EMG responses are monitored and used to adjust stimulation parameters. In response to detecting an unacceptable recording, electrical stimulation is applied to the peripheral nerve under open-loop control.

Abstract: A system, method, and apparatus for treating a medical condition by applying transcutaneous electrical stimulation to a target peripheral nerve of a subject. Electrical stimulation is applied to the peripheral nerve via a stimulation electrode pattern under closed-loop control in which EMG responses are monitored and used to adjust stimulation parameters. In response to detecting an unacceptable recording, electrical stimulation is applied to the peripheral nerve under open-loop control.

Abstract: A system, method, and apparatus for treating a medical condition by applying transcutaneous electrical stimulation to a target peripheral nerve of a subject. Electrical stimulation is applied to the peripheral nerve via a stimulation electrode pattern under closed-loop control in which EMG responses are monitored and used to adjust stimulation parameters. In response to detecting an unacceptable recording, electrical stimulation is applied to the peripheral nerve under open-loop control.

Abstract: An N-(azaaryl)cyclolactam-1-carboxamide derivative having a structure of formula (I), a preparation method therefor, and a use thereof are disclosed in the application. Each substituent are defined in the specification and claims. The series of compounds of the application can be widely applied in the preparation of drugs for treating cancer, tumor, autoimmune disease, metabolic disease or metastatic disease, particularly for treating ovarian cancer, pancreatic cancer, prostate cancer, breast cancer, cervical cancer, glioblastoma, multiple myeloma, metabolic disease, neurodegenerative disease, primary tumor site metastasis or osseous metastasis cancer, and are expected to be developed into a new generation of CSF-1R inhibitor drugs.

Abstract: A terminal wakeup method and an apparatus are disclosed. The method includes: if an access point fails to send a data frame to a station, and the access point fails to send a data frame to the station after channel switching, sending, by the access point, a wakeup signal to the station to wake up the station. According to the method, a data frame loss caused by channel switching can be reduced.

Abstract: An information storage system and apparatus relate to the field of automatic control technologies in order to resolve a problem that there is little information for diagnosing a fault that is stored using a freeze frame. The system includes at least one subcontroller configured to obtain a parameter value corresponding to a parameter, and send the parameter and the parameter value corresponding to the parameter to a management controller, the management controller configured to send the received parameter and the received parameter value corresponding to the parameter to a vehicle-intelligent device, and the vehicle-intelligent device is configured to receive and store the parameter and the parameter value corresponding to the parameter, where each subcontroller is coupled to at least one executor, and the management controller is coupled to each subcontroller of the at least one subcontroller.

Abstract: A terminal wakeup method and an apparatus are disclosed. The method includes: if an access point fails to send a data frame to a station, and the access point fails to send a data frame to the station after channel switching, sending, by the access point, a wakeup signal to the station to wake up the station. According to the method, a data frame loss caused by channel switching can be reduced.

Abstract: Provided is a thermal control enclosure, which includes a lower shell (1); and an upper cover (2) mounted above the lower shell (1) in a fitting manner, wherein a thermal energy reflecting film (3) is adhered to (an) inner surface(s) of the lower shell (1) and/or the upper cover (2), and the thermal energy reflecting film is a reflective metal film. The thermal control enclosure is simple in structure and low in cost, and surface temperature of the enclosure may be effectively controlled.

Abstract: Disclosed are processes and electrolytic cells that can be used to extract and thereby recover aluminum from aluminum-containing waste, including an aluminum dross that is suitable for disposal in a land-fill. The disclosed processes and cells use ionic liquids as an electrolyte.

Abstract: An estimation device and method are provided. A battery measurement platform sets up a communication with a measured battery, determines a model of the measured battery, and searches data of the measured battery according to the model thereof to obtain the state-of-charge of the measured battery. Accordingly, the estimation of the state-of-charge of batteries is performed on base of each battery, instead of on base of each battery measurement platform.